News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
95,200 Results
Type
Article (2932)
Company Profile (12)
Press Release (92256)
Multimedia
Podcasts (3)
Webinars (2)
Section
Business (36398)
Career Advice (63)
Deals (6120)
Drug Delivery (12)
Drug Development (11870)
Employer Resources (13)
FDA (1948)
Job Trends (2356)
News (54005)
Policy (3032)
Tag
Academia (229)
Accelerated approval (2)
Allergies (26)
Alliances (3638)
ALS (26)
Alzheimer's disease (218)
Antibody-drug conjugate (ADC) (43)
Approvals (2005)
Artificial intelligence (114)
Autoimmune disease (12)
Automation (10)
Bankruptcy (55)
Best Places to Work (2394)
BIOSECURE Act (3)
Biosimilars (31)
Biotechnology (11)
Bladder cancer (53)
Brain cancer (8)
Breast cancer (153)
Cancer (1104)
Cardiovascular disease (70)
Career advice (59)
Career pathing (2)
CAR-T (51)
CDC (3)
Cell therapy (138)
Cervical cancer (13)
Clinical research (11407)
Collaboration (361)
Compensation (408)
COVID-19 (288)
CRISPR (18)
C-suite (80)
Cystic fibrosis (29)
Data (1114)
Depression (14)
Diabetes (86)
Diagnostics (993)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (38)
Drug pricing (8)
Drug shortages (3)
Duchenne muscular dystrophy (30)
Earnings (31253)
Editorial (2)
Employer branding (1)
Employer resources (10)
Events (12138)
Executive appointments (338)
FDA (2570)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (351)
Gene editing (33)
Generative AI (3)
Gene therapy (102)
GLP-1 (166)
Government (384)
Grass and pollen (2)
Guidances (138)
Healthcare (2909)
HIV (22)
Huntington's disease (5)
IgA nephropathy (20)
Immunology and inflammation (23)
Immuno-oncology (3)
Indications (14)
Infectious disease (348)
Inflammatory bowel disease (28)
Influenza (19)
Intellectual property (26)
Interviews (7)
IPO (4709)
IRA (2)
Job creations (250)
Job search strategy (51)
Kidney cancer (6)
Labor market (5)
Layoffs (36)
Leadership (1)
Legal (525)
Liver cancer (20)
Longevity (2)
Lung cancer (174)
Lymphoma (82)
Machine learning (2)
Management (5)
Manufacturing (96)
MASH (28)
Medical device (2285)
Medtech (2285)
Mergers & acquisitions (1698)
Metabolic disorders (224)
Multiple sclerosis (28)
NASH (5)
Neurodegenerative disease (27)
Neuropsychiatric disorders (6)
Neuroscience (384)
NextGen: Class of 2025 (742)
Non-profit (546)
Obesity (117)
Opinion (8)
Ovarian cancer (34)
Pain (24)
Pancreatic cancer (35)
Parkinson's disease (45)
Patents (60)
Patient recruitment (49)
Peanut (15)
People (3776)
Pharmaceutical (6)
Pharmacy benefit managers (2)
Phase I (2982)
Phase II (4723)
Phase III (4509)
Pipeline (847)
Policy (13)
Postmarket research (438)
Preclinical (881)
Press Release (2)
Prostate cancer (62)
Psychedelics (7)
Radiopharmaceuticals (36)
Rare diseases (97)
Real estate (347)
Recruiting (2)
Regulatory (2642)
Reports (16)
Research institute (208)
Resumes & cover letters (4)
Rett syndrome (6)
RSV (25)
Schizophrenia (17)
Series A (52)
Series B (39)
Sickle cell disease (13)
Special edition (2)
Spinal muscular atrophy (13)
Sponsored (2)
Startups (209)
Stomach cancer (1)
Supply chain (30)
Tariffs (1)
The Weekly (3)
Vaccines (127)
Venture capital (8)
Weight loss (53)
Women's health (14)
Worklife (1)
Date
Today (34)
Last 7 days (132)
Last 30 days (689)
Last 365 days (11944)
2025 (6822)
2024 (8882)
2023 (7228)
2022 (8670)
2021 (8987)
2020 (8239)
2019 (6997)
2018 (5162)
2017 (4302)
2016 (3445)
2015 (4296)
2014 (2820)
2013 (1766)
2012 (2103)
2011 (2551)
2010 (2402)
Location
Africa (63)
Alabama (11)
Arizona (24)
Arkansas (4)
Asia (5111)
Australia (751)
California (3074)
Canada (689)
China (183)
Colorado (127)
Connecticut (153)
Delaware (124)
Europe (13505)
Florida (290)
Georgia (74)
Hawaii (1)
Idaho (7)
Illinois (240)
India (6)
Indiana (86)
Iowa (6)
Japan (121)
Kansas (11)
Kentucky (10)
Louisiana (6)
Maine (11)
Maryland (276)
Massachusetts (2307)
Michigan (88)
Minnesota (141)
Mississippi (1)
Missouri (31)
Montana (4)
Nebraska (2)
Nevada (29)
New Hampshire (22)
New Jersey (789)
New Mexico (6)
New York (685)
North Carolina (294)
North Dakota (2)
Northern California (1326)
Ohio (73)
Oklahoma (4)
Oregon (6)
Pennsylvania (419)
Puerto Rico (1)
Rhode Island (9)
South America (108)
South Carolina (3)
Southern California (1134)
Tennessee (55)
Texas (425)
United States (10045)
Utah (60)
Virginia (74)
Washington D.C. (17)
Washington State (220)
West Virginia (3)
Wisconsin (55)
95,200 Results for "36".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adial Pharmaceuticals Announces Pricing of $3.6 Million Public Offering
June 18, 2025
·
6 min read
Press Releases
OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025
June 23, 2025
·
11 min read
Press Releases
North America Next Generation Sequencing Market Size Accelerates Toward USD 36.87 Billion at 21.93% CAGR by 2034
June 25, 2025
·
1 min read
Weight loss
Metsera Shares Rise as Monthly Weight Loss Injection Shaves Over 8% Body Weight at 36 Days
In what Guggenheim Partners called one of Metsera’s “critical program milestones” this year, its ultra-long-acting amylin injection MET-233i showed promising weight-loss after a little more than a month of treatment.
June 9, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025
April 7, 2025
·
5 min read
Press Releases
RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025
May 12, 2025
·
7 min read
Press Releases
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
April 29, 2025
·
6 min read
Press Releases
Pilatus Biosciences Publishes Preclinical Data in Cancer Discovery on PLT012 First-in-Class CD36-Targeting Antibody for Liver Cancer
April 30, 2025
·
4 min read
Press Releases
U.S. Concierge Medicine Market Size Boosts 10.36% CAGR by 2034
February 26, 2025
·
1 min read
Press Releases
UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates
May 5, 2025
·
9 min read
1 of 9,520
Next
